Literature DB >> 21080074

Assessment of the serial changes of vessel wall contents in atherosclerotic coronary lesion with bioresorbable everolimus-eluting vascular scaffolds using Shin's method: an IVUS study.

Eun-Seok Shin1, Hector M Garcia-Garcia, Scot Garg, Jurgen Ligthart, Leif Thuesen, Dariusz Dudek, John A Ormiston, Patrick W Serruys.   

Abstract

Although serial changes in necrotic core and calcium are regarded as surrogates for the bioresorption process in patients treated with the bioresorbable everolimus-eluting vascular scaffolds (BVS), these temporal changes have not yet been fully investigated. Shin's method may be offer a more suitable technique for this analysis because it includes all the contents of both the lumen and vessel wall. The purpose of this study was to assess the serial changes of necrotic core and dense calcium content in coronary lesions that were treated with a BVS implant using Virtual Histology intravascular ultrasound (VH-IVUS) analyzed using Shin's method. A total of 29 patients (92 coronary segments) were imaged to evaluate the serial changes in necrotic core and dense calcium using Shin's method. Lesions treated with a BVS implant were analyzed with serial VH-IVUS assessments, i.e., pre- and post-stenting, and at 6 months and 2 years follow-up. In Shin's method contours are drawn around the IVUS catheter (instead of delineating the lumen) and the vessel. The mean necrotic core area decreased by 6.9% from post-stenting to 6 months (1.71 ± 1.03 mm² vs. 1.36 ± 0.91 mm², P = 0.027), and by 20.5% (1.71 ± 1.03 mm² vs. 1.20 ± 0.70 mm², P = 0.003) from post-steting to 2 years; while the mean dense calcium areas decreased by 27.2% (1.07 ± 0.55 mm² vs. 0.78 ± 0.64 mm², P = 0.039) from post-stenting and 2 years. At 2 years, absolute necrotic core and dense calcium content were significantly decreased as compared to post-stenting values. The present study demonstrates that the bioresorption process in patients who undergoing BVS device implantation can be assessed using VH-IVUS analysed using Shin's method.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21080074     DOI: 10.1007/s10554-010-9739-4

Source DB:  PubMed          Journal:  Int J Cardiovasc Imaging        ISSN: 1569-5794            Impact factor:   2.357


  6 in total

1.  Artifact-free coronary magnetic resonance angiography and coronary vessel wall imaging in the presence of a new, metallic, coronary magnetic resonance imaging stent.

Authors:  Elmar Spuentrup; Alexander Ruebben; Andreas Mahnken; Matthias Stuber; Christian Kölker; Trung Hieu Nguyen; Rolf W Günther; Arno Buecker
Journal:  Circulation       Date:  2005-02-21       Impact factor: 29.690

2.  Reproducibility of intravascular ultrasound radiofrequency data analysis: implications for the design of longitudinal studies.

Authors:  Gastón A Rodriguez-Granillo; Sophia Vaina; Héctor M García-García; Marco Valgimigli; Eric Duckers; Robert J van Geuns; Evelyn Regar; William J van der Giessen; Marco Bressers; Dick Goedhart; Marie-Angele Morel; Pim J de Feyter; Patrick W Serruys
Journal:  Int J Cardiovasc Imaging       Date:  2006-03-31       Impact factor: 2.357

3.  A bioabsorbable everolimus-eluting coronary stent system (ABSORB): 2-year outcomes and results from multiple imaging methods.

Authors:  Patrick W Serruys; John A Ormiston; Yoshinobu Onuma; Evelyn Regar; Nieves Gonzalo; Hector M Garcia-Garcia; Koen Nieman; Nico Bruining; Cécile Dorange; Karine Miquel-Hébert; Susan Veldhof; Mark Webster; Leif Thuesen; Dariusz Dudek
Journal:  Lancet       Date:  2009-03-14       Impact factor: 79.321

4.  Assessment of the absorption process following bioabsorbable everolimus-eluting stent implantation: temporal changes in strain values and tissue composition using intravascular ultrasound radiofrequency data analysis. A substudy of the ABSORB clinical trial.

Authors:  Héctor M García-García; Nieves Gonzalo; Ravindra Pawar; Neville Kukreja; Dariusz Dudek; Leif Thuesen; John A Ormiston; Evelyn Regar; Patrick W Serruys
Journal:  EuroIntervention       Date:  2009-01       Impact factor: 6.534

5.  A bioabsorbable everolimus-eluting coronary stent system for patients with single de-novo coronary artery lesions (ABSORB): a prospective open-label trial.

Authors:  John A Ormiston; Patrick W Serruys; Evelyn Regar; Dariusz Dudek; Leif Thuesen; Mark W I Webster; Yoshinobu Onuma; Hector M Garcia-Garcia; Robert McGreevy; Susan Veldhof
Journal:  Lancet       Date:  2008-03-15       Impact factor: 79.321

6.  A new method to measure necrotic core and calcium content in coronary plaques using intravascular ultrasound radiofrequency-based analysis.

Authors:  Eun-Seok Shin; Hector M Garcia-Garcia; Patrick W Serruys
Journal:  Int J Cardiovasc Imaging       Date:  2010-01-09       Impact factor: 2.357

  6 in total
  1 in total

Review 1.  Cardiovascular imaging 2011 in the International Journal of Cardiovascular Imaging.

Authors:  Ricardo A Costa; Hiram G Bezerra; Johan H C Reiber; Frank J Rybicki; Paul Schoenhagen; Arthur A Stillman; Johan De Sutter; Nico R L Van de Veire; Ernst E van der Wall
Journal:  Int J Cardiovasc Imaging       Date:  2012-03       Impact factor: 2.357

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.